News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,214 Results
Type
Article (206)
Company Profile (1)
Press Release (4007)
Section
Business (1385)
Career Advice (14)
Deals (143)
Drug Development (578)
Employer Resources (1)
FDA (55)
Job Trends (63)
News (2098)
Policy (118)
Tag
Academia (18)
Alliances (346)
ALS (3)
Alzheimer's disease (75)
Antibody-drug conjugate (ADC) (2)
Approvals (58)
Artificial intelligence (2)
Automation (2)
Best Places to Work (51)
Biotechnology (2)
Cancer (9)
Career advice (10)
Career pathing (2)
Clinical research (480)
Collaboration (7)
Compensation (1)
COVID-19 (13)
CRISPR (1)
C-suite (5)
Data (33)
Diagnostics (16)
Diversity, equity & inclusion (1)
Drug discovery (2)
Earnings (373)
Employer resources (1)
Events (550)
Executive appointments (7)
FDA (70)
Funding (7)
Gene editing (1)
Gene therapy (5)
GLP-1 (4)
Government (12)
Guidances (4)
Healthcare (92)
Huntington's disease (5)
Immunology and inflammation (1)
Infectious disease (13)
Intellectual property (1)
Interviews (2)
IPO (42)
Job creations (15)
Job search strategy (8)
Layoffs (6)
Leadership (1)
Legal (25)
Manufacturing (5)
Medical device (44)
Medtech (44)
Mergers & acquisitions (108)
Neurodegenerative disease (11)
Neuropsychiatric disorders (2)
Neuroscience (94)
NextGen: Class of 2026 (41)
Non-profit (16)
Pain (2)
Parkinson's disease (3)
Patents (2)
Patient recruitment (3)
People (587)
Phase 1 (126)
Phase 2 (278)
Phase 3 (166)
Pipeline (26)
Postmarket research (3)
Preclinical (54)
Press Release (1)
Rare diseases (9)
Real estate (62)
Regulatory (111)
Reports (1)
Research institute (14)
Resumes & cover letters (3)
Schizophrenia (5)
Series A (1)
Series B (1)
Sponsored (1)
Startups (19)
Vaccines (2)
Date
Last 7 days (2)
Last 30 days (9)
Last 365 days (153)
2026 (13)
2025 (154)
2024 (160)
2023 (163)
2022 (352)
2021 (335)
2020 (278)
2019 (230)
2018 (186)
2017 (206)
2016 (200)
2015 (239)
2014 (204)
2013 (165)
2012 (188)
2011 (241)
2010 (163)
Location
Africa (6)
Asia (115)
Australia (23)
California (18)
Canada (8)
China (4)
Colorado (4)
Connecticut (3)
Europe (542)
Florida (3)
Illinois (3)
Indiana (1)
Japan (2)
Massachusetts (34)
Michigan (1)
Missouri (3)
Nevada (1)
New Jersey (9)
New York (113)
North Carolina (4)
Northern California (9)
Ohio (2)
Oregon (1)
Pennsylvania (2)
South America (6)
Southern California (6)
Texas (4)
United States (203)
Washington State (1)
4,214 Results for "sigma aldrich".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome
January 19, 2026
·
4 min read
Rare diseases
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a non-profit sponsor to win FDA approval.
December 10, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Fondazione Telethon Announces FDA approval of Waskyra™ (etuvetidigene autotemcel), a Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
December 10, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University
December 16, 2025
·
12 min read
BioMidwest
Sigma-Aldrich and Genoway Expand Their CRISPR/CAS9 Strategic Alliance
Sigma-Aldrich Co LLC and genOway announced a new structure to their 2018 strategic alliance in the CRISPR/Cas9 field.
September 8, 2022
·
3 min read
Business
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024.
February 29, 2024
·
2 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Drug Development
Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases
Cognition Therapeutics, Inc. (NASDAQ: CGTX) is presenting in vivo preclinical results at the Society for Neuroscience’s annual meeting illuminating the role of sigma-2 (σ-2) receptor modulators, including CT1812, in models of Alzheimer’s and Parkinson’s diseases.
November 15, 2023
·
6 min read
Press Releases
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025
·
4 min read
Business
KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer
KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer.
May 10, 2023
·
4 min read
1 of 422
Next
